ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Recursos principais

Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
iShares MSCI Pacific ex Japan

iShares MSCI Pacific ex Japan (EPP)

44,34
0,13
(0,29%)
No fechamento: 06 Janeiro 6:00PM
44,34
0,00
( 0,00% )
Após o horário de negociação: 8:20PM

Calls

StrikeOfertaVendaÚltimo PreçoPonto MédioVariação do DiaVariação do Dia %VolumeINT ABERTOÚltimo Negócio
34,009,0011,900,0010,450,000,00 %00-
35,007,4011,700,009,550,000,00 %00-
36,007,0010,400,008,700,000,00 %00-
37,006,009,700,007,850,000,00 %00-
38,004,807,900,006,350,000,00 %00-
39,003,307,500,005,400,000,00 %00-
40,002,306,200,004,250,000,00 %00-
41,001,504,900,003,200,000,00 %00-
42,000,803,900,002,350,000,00 %00-
43,001,404,000,002,700,000,00 %00-
44,000,652,450,001,550,000,00 %00-
45,000,102,050,001,0750,000,00 %00-
46,002,251,252,251,750,000,00 %01-
47,001,751,301,751,5250,000,00 %03-
48,002,110,502,111,3050,000,00 %015-
49,000,600,500,600,550,000,00 %02-
50,000,350,500,350,4250,000,00 %03-
51,000,300,500,300,400,000,00 %01-
52,000,000,500,000,000,000,00 %00-
53,000,000,500,000,000,000,00 %00-

Capacite seu portfólio: Discussões em tempo real e ideias de negociação acionáveis.

Puts

StrikeOfertaVendaÚltimo PreçoPonto MédioVariação do DiaVariação do Dia %VolumeINT ABERTOÚltimo Negócio
34,000,000,500,000,000,000,00 %00-
35,000,000,500,000,000,000,00 %00-
36,000,000,500,000,000,000,00 %00-
37,000,000,500,000,000,000,00 %00-
38,000,000,500,000,000,000,00 %00-
39,000,000,500,000,000,000,00 %00-
40,000,000,500,000,000,000,00 %00-
41,000,000,500,000,000,000,00 %00-
42,000,001,400,000,000,000,00 %00-
43,000,002,050,000,000,000,00 %00-
44,000,002,050,000,000,000,00 %00-
45,000,302,601,001,450,000,00 %01-
46,001,254,701,352,9750,000,00 %01-
47,001,054,101,852,5750,000,00 %02-
48,001,355,600,003,4750,000,00 %00-
49,002,306,203,004,250,000,00 %01-
50,003,807,200,005,500,000,00 %00-
51,004,508,600,006,550,000,00 %00-
52,005,309,200,007,250,000,00 %00-
53,007,2010,100,008,650,000,00 %00-

Rankings

Ver todos
  • Volume
  • % Altas
  • % Quedas
CódigoPreçoVol.
MSAIMultiSensor AI Holdings Inc
US$ 2,80
(40,00%)
2,52M
MCVTMill City Ventures III Ltd
US$ 3,10
(37,17%)
85,45k
XTIAXTI Aerospace Inc
US$ 0,1115
(26,70%)
362,56M
QRTEBQurate Retail Inc
US$ 3,13
(22,27%)
103
NARIInari Medical Inc
US$ 78,80
(21,23%)
4,7M
AMSTAmesite Inc
US$ 3,38
(-16,54%)
59,87k
GDTCCytoMed Therapeutics Ltd
US$ 2,89
(-15,74%)
61,92k
ENVBEnveric Biosciences Inc
US$ 0,3568
(-15,55%)
377,21k
ACXPAcurx Pharmaceuticals Inc
US$ 0,924
(-15,23%)
165,97k
SLRNACELYRIN Inc
US$ 2,98
(-14,61%)
505,98k
XTIAXTI Aerospace Inc
US$ 0,1115
(26,70%)
362,56M
SVMHSRIVARU Holding Ltd
US$ 0,0519
(12,10%)
29,45M
CRKNCrown Electrokinetics Corporation
US$ 0,1401
(5,34%)
25,17M
CEROCERo Therapeutics Holdings Inc
US$ 0,0489
(15,60%)
17,02M
CDTConduit Pharmaceuticals Inc
US$ 0,0827
(14,38%)
16,62M
La Flaca La Flaca 41 segundos atrás
Alot hinges on EMA approval so it makes sense that Anavex is positioning itself for maximum visibility with journal articles, presentations, OLE data presentation. The drug seems to be effective if taken early enough. I hope this is top of mind during EMA approval process. That's the bottom line - t
AVXL
TheKid5 TheKid5 44 segundos atrás
$0.00000000000000000000000
TPTW
dia76ca dia76ca 46 segundos atrás
PRIORITY REVIEW (FDA)
"Prior to approval, each drug marketed in the United States must go through a detailed FDA review process. In 1992, under the Prescription Drug User Act (PDUFA), FDA agreed to specific goals for improving the drug review time and created a two-tiered system of review tim
AVXL
Threes Threes 58 segundos atrás
They probably had buyers in Ampersand in the waiting. Nick getting his ill gotten gains while they consolidate the shares.
CDMO
ThunderousSeer8 ThunderousSeer8 1 min atrás
There's a lot of human behavior and psychology in investing. I think they can't understand what it's even like to be a person that has a sustainable future regardless of how this turns out. Their perspectives are so limited and their ability to analyze themselves is lacking. I wish you all the best
RDAR
flipper44 flipper44 1 min atrás
I think the short positions that bought warrants with their initial proceeds, can cover their short shares by exercising an equal number of warrants at a fixed low price. There are 47 million short shares, some of which may be hedged with warrants.

I don’t know enough about timing
NWBO
DrivenByPain DrivenByPain 3 minutos atrás
SGDH Security Details Updated Today No Change 01/06/2025 https://www.otcmarkets.com/stock/SGDH/security
SGDH
ergo sum ergo sum 3 minutos atrás
The democrats gave away the election and now like to pretend how polite they are surrendering power.
looking 4 a win looking 4 a win 4 minutos atrás
Great question, pigs don't always get slaughtered. Sometimes they go on to become pig kings! 
Anyway, also- foubl?
BB
barnyarddog barnyarddog 4 minutos atrás
https://www.stocktitan.net/news/BAYA/
BAYA
marcis marcis 4 minutos atrás
Yes good post.
Same here, I don’t have to react when I see a pullback.
In fact seeing these guys show up all of a sudden spewing no one knows blah blah blah
It all was in order, which will be soon, the share price will be 1000x current

They do scare half knowledg
RDAR
chainma1l chainma1l 4 minutos atrás
Probably just naked shorties or MM manipulators!
TO DA MOOON!

What an amazing company.
Goo VPER
VPER
jmhgolf jmhgolf 4 minutos atrás
What is that? 
DRGV
Trinityz1 Trinityz1 4 minutos atrás
thx, first time have seen that
badog badog 6 minutos atrás
I never had the link. I wouldn't open a link by a person who posted for the first time. Homebrew may have it.
Badog
ERHE
Investor2014 Investor2014 6 minutos atrás
Yes EMA approval may result in a limited label FDA conditional approval requiring a confirmatory trial that shows dose dependence, is longer and larger with diverse ethnicity.
AVXL
ThunderousSeer8 ThunderousSeer8 7 minutos atrás
Yes. I am invested here and in many other markets. I've been here since April of this year. These guys just can't cut it, man. You can see it in the frequency of their posts. They live for this, they absolutely think highly of themselves even though the frequency at which they post shows they haven'
RDAR
longrider51 longrider51 7 minutos atrás
Recall and consider the source, right?
This article appeared on National Review (Online) on January 24, 2021.
Note National Review is distinctly a politically right oriented outfit ..
https://mediabiasfactcheck.com/national-review/ .
PickStocks PickStocks 7 minutos atrás
Tell everyone again how you are a crypto guru.....did you take advice from the hawk Tuah girl...
COOP
SSKILLZ1 SSKILLZ1 7 minutos atrás
OPTT Was the best performing stock pick today picked by NSOMNIYAK and the Best Top Pick was OPTT picked by NSOMNIYAK. hope this helps.
OPTT
XMaster2023 XMaster2023 9 minutos atrás
You missed the point EX. The demand for C-19 vaccines is diminishing. Why is Merck spending 500 mil to increase capacity?
Perhaps they want to help out their Chinese competitors?
Perhaps they need more Vaccine capacity?
Perhaps they already have a deal cut with NWBO and it i
NWBO
Juststoppingby Juststoppingby 10 minutos atrás
It looks like they still need to comply with rule 15c2-11, which took effect not too long ago.

How to Become Quoted on the Pink Market
To be eligible for quotations, companies must:
1. Comply with the requirements of Securities Exchange Act Rule 15c2-11
2. Make cu
CRTG

Seu Histórico Recente